{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:30:40Z","timestamp":1694068240810},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":293,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1111\/bjd.13170","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T06:38:50Z","timestamp":1402123130000},"page":"253-256","source":"Crossref","is-referenced-by-count":7,"title":["Use of imatinib in a patient with cutaneous vasculopathy in the context of von Recklinghausen disease\/neurofibromatosis"],"prefix":"10.1093","volume":"172","author":[{"given":"I.","family":"Khelifa","sequence":"first","affiliation":[{"name":"Department of Dermatology; University Hospital of Geneva; 4 Rue Gabrielle Perret-Gentil Geneva 1205 Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Saurat","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospital of Geneva; 4 Rue Gabrielle Perret-Gentil Geneva 1205 Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospital of Geneva; 4 Rue Gabrielle Perret-Gentil Geneva 1205 Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"10.1111\/bjd.13170-BIB0001|bjd13170-cit-0001","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"DeClue","year":"1992","journal-title":"Cell"},{"key":"10.1111\/bjd.13170-BIB0002|bjd13170-cit-0002","first-page":"463","article-title":"Neuromatosis et lesions vasculaires","volume":"75","author":"Reubi","year":"1945","journal-title":"Sch Med Wochens"},{"key":"10.1111\/bjd.13170-BIB0003|bjd13170-cit-0003","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/hmg\/ddn134","article-title":"Nf1+\/\u2212 mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway","volume":"17","author":"Lasater","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1111\/bjd.13170-BIB0004|bjd13170-cit-0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ajmg.a.33788","article-title":"Cerebrovasculopathy in NF1 associated with ocular and scalp defects","volume":"155","author":"Smith","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1111\/bjd.13170-BIB0005|bjd13170-cit-0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1538574412454583","article-title":"The endovascular management of a neurofibromatosis vasculopathy: a case report","volume":"46","author":"Choong","year":"2012","journal-title":"Vasc Endovascular Surg"},{"key":"10.1111\/bjd.13170-BIB0006|bjd13170-cit-0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/1096-8628(20010422)100:2<95::AID-AJMG1235>3.0.CO;2-T","article-title":"Cardiac findings in an individual with neurofibromatosis 1 and sudden death","volume":"100","author":"Hamilton","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1111\/bjd.13170-BIB0007|bjd13170-cit-0007","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1212\/01.WNL.0000150544.00016.69","article-title":"Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1","volume":"64","author":"Rosser","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/bjd.13170-BIB0008|bjd13170-cit-0008","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/jnnp.2007.136457","article-title":"Cerebrovascular dysplasia in neurofibromatosis type 1","volume":"79","author":"Cairns","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/bjd.13170-BIB0009|bjd13170-cit-0009","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jaad.2004.04.004","article-title":"Skin ulcerations as manifestation of vasculopathy in neurofibromatosis","volume":"51","author":"Ljunggren","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13170-BIB0010|bjd13170-cit-0010","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.jaad.2003.11.074","article-title":"Vasculopathy in von Recklinghausen's neurofibromatosis-a diagnostic quandary","volume":"50","author":"Obermoser","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13170-BIB0011|bjd13170-cit-0011","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI41443","article-title":"Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans","volume":"120","author":"Lasater","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.13170-BIB0012|bjd13170-cit-0012","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2212 and c-kit-dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1111\/bjd.13170-BIB0013|bjd13170-cit-0013","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1111\/bjd.13170-BIB0014|bjd13170-cit-0014","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/pbc.24281","article-title":"Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas","volume":"60","author":"Kim","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/bjd.13170-BIB0015|bjd13170-cit-0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.186.3.291","article-title":"Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension","volume":"186","author":"Tamura","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13170","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13170\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:10:30Z","timestamp":1676383830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/1\/253\/6615835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13170","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}